Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$69,689,751
+$32,690,007 QoQ
Shares Held
1,970,864
+49.0% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
2.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $344,937,665 across 8 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
187,187 | $110,998,147 | |
| 2 | ALKS |
Alkermes plc.
This page
|
1,970,864 | $69,689,751 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
820,243 | $63,076,686 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,274,000 | $38,831,520 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
521,353 | $25,103,146 | |
| 6 | ORGO |
Organogenesis Holdings Inc.
|
10,085,951 | $23,903,703 | |
| 7 | EOLS |
Evolus, Inc.
|
2,245,360 | $9,228,429 | |
| 8 | ETON |
Eton Pharmaceuticals, Inc.
|
166,381 | $4,106,283 |
All Filings in ALKS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $69,689,751 | 1,970,864 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $36,999,744 | 1,322,364 | Shares | Sole | 2026-02-12 | |
| 2023-09-30 | $1,523,744 | 54,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,084,720 | 194,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,483,700 | 230,000 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||